Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN)

National Defense Medical Center, Taiwan

Status: Completed

Conditions: Osteoporosis; Osteoporotic Fractures

Treatments: Other: AI-enabled Chest X-ray-based Screening Tool

Study type: Interventional

Funder types: Other

Identifiers

NCT05721157

NDMC2023001

Details and patient eligibility

About

Artificial Intelligence-assisted Diagnosis and Prognostication in Osteoporosis Using Chest X-ray

Enrollment: 4,912 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients recieved at least 1 chest X-ray examination in 2022
• More than 66% chest X-ray identified as high risk of osteoporosis by AI-CXR

Exclusion criteria

• Patients with history of at least 1 dual energy x-ray absorptiometry (DXA)
• Patients with history of osteoporosis or osteoportic fracture
• Patients recieved prescription anti-osteoporotic treatment (excluding vitamin D or calcium)
• Patients died before 01 Jan 2023

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

4,912 participants in 2 patient groups

Intervention

Experimental group

Description:

Patients randomized to intervention will have access to the screening tool.

Treatment:

Other: AI-enabled Chest X-ray-based Screening Tool

Control

No Intervention group

Description:

Patients randomized to control will continue routine practice.